<DOC>
	<DOCNO>NCT02485600</DOCNO>
	<brief_summary>This open-label , postmarketing , observational study document health outcome , Canadian patient advance Parkinson 's disease long-term treatment Duodopa ( levodopa/carbidopa intestinal gel ) .</brief_summary>
	<brief_title>Observational Study Evaluating Long-term Health Outcomes Canadian DUODOPA-treated Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosed advance Parkinson 's Disease Prescribed Duodopa his/her treat physician . Patients previously treat Duodopa . Presence condition , opinion treat physician , prohibits patient participate study obscures assessment treatment advance PD .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>LCIG</keyword>
	<keyword>Duodopa</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Observational</keyword>
	<keyword>Cadence</keyword>
	<keyword>Levodopa-carbidopa intestinal gel</keyword>
</DOC>